Latest Breaking News On - Epilepsy therapies - Page 1 : comparemela.com

Capsida Biotherapeutics to Present New Preclinical Data on Potential of Systemically Delivered Next-Generation AAV Therapeutics for Treatment of Genetic Epilepsy

/PRNewswire/ Capsida Biotherapeutics ("Capsida") today announced it will present new preclinical data showing the potential for its engineered.

Nicholas flytzanisSusan catalanoPrnewswire capsida biotherapeuticsPeter anastasiouMingshan xueEpilepsy therapies diagnostics development symposiumBaylor college of medicineEpilepsy therapiesDiagnostics development symposiumBaylor collegeGenetic epilepsy causedGenetic epilepsyCapsida biotherapeuticsHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveries

Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights

Presented initial preclinical data from ETX-123, Eliem s lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed mechanism of action on neuronal excitability . | May 11, 2023

United kingdomChris brinzeyMarites coulterAndrew levinEliem therapeutics incProgram updatesInternational kvEpilepsy therapies diagnostics developmentIon channelsTherapeutic targetsEpilepsy therapiesDiagnostics developmentAnticipated keyEliem therapeuticsQuarterly reportConsolidated statements

Eliem Therapeutics Reports First Quarter Financial Results

Presented initial preclinical data from ETX-123, Eliem's lead Kv7 program candidate, demonstrating a promising profile and confirming the proposed.

United kingdomAndrew levinChris brinzeyMarites coulterInternational kvEliem therapeutics incEpilepsy therapies diagnostics developmentProgram updatesIon channelsTherapeutic targetsEpilepsy therapiesDiagnostics developmentAnticipated keyEliem therapeuticsQuarterly reportConsolidated statements

Epilepsy Market Registers 14 5% CAGR with Impressive Growth Opportunities During the Study Period [2017-2030], Ascertains DelveInsight

Epilepsy Market Registers 14 5% CAGR with Impressive Growth Opportunities During the Study Period [2017-2030], Ascertains DelveInsight
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomShruti thakurDainippon sumitomo pharmaNeurocrine biosciencesPrnewswire delveinsightZynerba pharma zygelZynerba pharmaZebinix aptiomEncephalopathies deesDainippon sumitomo pharma eisaiBiopharma padsevonilMallinckrodt pharmaceuticalsJazz pharmaceuticalsMarket companiesXenon pharmaceuticals